Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
The provided UK guideline context does not contain specific information regarding the role of intravitreal injections in the management of retinal vein occlusion or which patients are most likely to benefit from them for this condition.
The guidelines discuss intravitreal anti-VEGFs and steroid implants in the context of managing visual impairment caused by diabetic macular oedema and proliferative diabetic retinopathy NICE NG242. They also cover anti-VEGF therapies for neovascular age-related macular degeneration NICE CKS,NICE CKS.